Stay updated on Argonaut Clinical Trial: BBP-398 & Sotorasib in KRAS-G12C
Sign up to get notified when there's something new on the Argonaut Clinical Trial: BBP-398 & Sotorasib in KRAS-G12C page.

Latest updates to the Argonaut Clinical Trial: BBP-398 & Sotorasib in KRAS-G12C page
- Check2 days agoChange DetectedThe study record for the Phase 1 BBP-398 and sotorasib trial is now displayed, including its design, eligibility criteria, outcomes, and locations. It states that the study has been terminated for business reasons and is no longer recruiting participants.SummaryDifference64%

- Check9 days agoChange DetectedThe ClinicalTrials.gov footer now displays revision v3.7.1 instead of v3.7.0. The page continues to show a 403 error.SummaryDifference0.2%

- Check16 days agoNo Change Detected
- Check30 days agoChange DetectedThe page now shows a 403 Forbidden error instead of the usual study details, indicating access to the study information is blocked.SummaryDifference19%

- Check51 days agoChange DetectedThe study record version has been updated from v3.6.5 to v3.6.6, signaling a refreshed version of the page with likely minor edits rather than substantive changes to study details.SummaryDifference0.0%

- Check72 days agoChange DetectedRevision updated from v3.6.4 to v3.6.5 on the page, signaling a new version of the study details page. This reflects a metadata update rather than a change to visible content.SummaryDifference0.0%

- Check86 days agoChange DetectedThe page's revision label was updated from v3.6.3 to v3.6.4, signaling a small update to the page's metadata.SummaryDifference0.0%

Stay in the know with updates to Argonaut Clinical Trial: BBP-398 & Sotorasib in KRAS-G12C
Enter your email address, and we'll notify you when there's something new on the Argonaut Clinical Trial: BBP-398 & Sotorasib in KRAS-G12C page.